Comparative efficacy of incretin drugs on glycemic control, body weight, and blood pressure in adults with overweight or obesity and with/without type 2 diabetes: a systematic review and network meta-analysis

Comparative efficacy of incretin drugs on glycemic control, body weight, and blood pressure in adults with overweight or obesity and with/without type 2 diabetes: a systematic review and network meta-analysis

Journal Article SummaryThe article investigates the effectiveness and safety of multi-receptor drugs targeting glucagon-like peptide-1 receptors (GLP-1R) in adults with overweight or obesity, both with and without type 2 diabetes. This topic is significant due to the...
Comparative efficacy of incretin drugs on glycemic control, body weight, and blood pressure in adults with overweight or obesity and with/without type 2 diabetes: a systematic review and network meta-analysis

A Comprehensive Review on the Pharmacokinetics and Drugāˆ’Drug Interactions of Approved GLP-1 Receptor Agonists and a Dual GLP-1/GIP Receptor Agonist

Journal Article SummaryThe journal article focuses on the pharmacokinetics and potential drug-drug interactions (DDIs) of GLP-1 receptor agonists (GLP-1 RAs) and a newly approved dual GLP-1/GIP receptor agonist, tirzepatide. These medications are primarily used to...
Comparative efficacy of incretin drugs on glycemic control, body weight, and blood pressure in adults with overweight or obesity and with/without type 2 diabetes: a systematic review and network meta-analysis

Semaglutide Versus Other Glucagon-Like Peptide-1 Agonists for Weight Loss in Type 2 Diabetes Patients: A Systematic Review and Meta-Analysis

Journal Article SummaryThe article examines the effectiveness of semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA), in promoting weight loss among patients with type 2 diabetes compared to other GLP-1 agonists like liraglutide and dulaglutide. Given...